Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment
- PMID: 18402507
Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment
Abstract
Parkinson's disease (PD) is a chronic neurodegenerative disease associated with substantial morbidity, increased mortality, and high economic burden. Of importance to managed care is that the number of cases of PD are on the rise, paralleling the advancing age of the population, and misdiagnosis is common. Effective management of PD can minimize disability and potentially improve long-term outcomes, which would minimize long-term healthcare costs and medical resource utilization. This article provides a brief review of the epidemiology, pathophysiology, clinical course, and burden of PD.
Similar articles
-
Parkinson's disease--Part 2: Treatment of motor symptoms.Am J Manag Care. 2008 Mar;14(2 Suppl):S49-58. Am J Manag Care. 2008. PMID: 18402508 Review.
-
The economic impact of Parkinson's disease.Parkinsonism Relat Disord. 2007 Sep;13 Suppl:S8-S12. doi: 10.1016/j.parkreldis.2007.06.003. Epub 2007 Aug 16. Parkinsonism Relat Disord. 2007. PMID: 17702630 Review.
-
Mutuality of the marital relationship in Parkinson's disease.Mov Disord. 2008 Oct 15;23(13):1843-9. doi: 10.1002/mds.22089. Mov Disord. 2008. PMID: 18759355
-
Costs of Parkinson's disease in eastern Europe: a Czech cohort study.Parkinsonism Relat Disord. 2010 Jan;16(1):51-6. doi: 10.1016/j.parkreldis.2009.07.005. Epub 2009 Aug 8. Parkinsonism Relat Disord. 2010. PMID: 19665915
-
Implications for managed care for improving outcomes in Parkinson's disease: balancing aggressive treatment with appropriate care.Am J Manag Care. 2011 Oct;17 Suppl 12:S322-7. Am J Manag Care. 2011. PMID: 22087553 Review.
Cited by
-
Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson's Disease in 204 Countries/Territories From 1990 to 2019.Front Public Health. 2021 Dec 7;9:776847. doi: 10.3389/fpubh.2021.776847. eCollection 2021. Front Public Health. 2021. PMID: 34950630 Free PMC article.
-
Economic evaluation of ropinirole prolonged release for treatment of Parkinson's disease in the Netherlands.Drugs Aging. 2014 Mar;31(3):193-201. doi: 10.1007/s40266-013-0150-4. Drugs Aging. 2014. PMID: 24399580
-
Alpha-synuclein and tau: teammates in neurodegeneration?Mol Neurodegener. 2014 Oct 29;9:43. doi: 10.1186/1750-1326-9-43. Mol Neurodegener. 2014. PMID: 25352339 Free PMC article. Review.
-
Parkinson's disease: current assessment methods and wearable devices for evaluation of movement disorder motor symptoms - a patient and healthcare professional perspective.BMC Neurol. 2020 Nov 18;20(1):419. doi: 10.1186/s12883-020-01996-7. BMC Neurol. 2020. PMID: 33208135 Free PMC article.
-
The effects of transcranial magnetic stimulation for freezing of gait in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials.Front Aging Neurosci. 2024 Feb 2;16:1304852. doi: 10.3389/fnagi.2024.1304852. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38371401 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical